You appear to be using an older version of Internet Explorer. We suggest you upgrade your browser for the best viewing experience. Upgrade to a Modern Browser
Antibody therapeutics is a rapidly developing field, with many antibody-based therapies now on the market and in the clinic. Patenting of antibodies, particularly for known targets, is proving increasingly difficult. The day-to day practice at the European Patent Office is constantly evolving, moving forward much faster than the Case Law. This webinar makes use of the significant experience of J A Kemp’s attorneys in prosecuting antibody cases at the European Patent Office, as well as discussions with EPO examiners, highlighting recent trends in examination and strategies for addressing objections.
Topics include: